Practice
Featured experience
MSG Networks comprehensive out-of-court debt restructuring
We advised the administrative agent and a lender on the transaction
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Eli Lilly $6.5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
Deutsche Bank $1 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2028
Air Products and Chemicals $2.5 billion green notes offering
The investment-grade notes are due 2029, 2031 and 2034
Texas Instruments $3 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Morgan Stanley $1.5 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering